PBX3 and cervical carcinoma: The knockdown of PBX3 in cervical cancer cells was found to inhibit cell proliferation in vitro and tumour size and weight in vivo via the inactivation of the PI3K/AKT signalling pathway via downregulating p‐AKT expression.82